FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995367063> ?p ?o ?g. }

• W1995367063 endingPage "2630" @default.
• W1995367063 startingPage "2630" @default.
• W1995367063 abstract "To investigate the effect of high dose glargine on the expression profiles of microRNAs in human pancreatic cancer cells.Real-time polymerase chain reaction array (RT-PCR) was applied to investigate miRNAs differentially expressed in Sw1990 cells treated with or without 100 IU/L glargine. Stem-loop RT-PCR was used to confirm the results of the array assay in Sw1990 and Panc-1 cells. The effects of miR-95 on cell growth, apoptosis, invasion and migration abilities were respectively examined by CCK8 assay, apoptosis assay, Matrigel invasion and migration assay in Sw1990 and Panc-1 cells. Nude mice xenograft models with Sw1990 cells were built to investigate pancreatic cancer growth in vivo after transfection by the lentivirus pGLV3-GFP- miR-95.Ten miRNAs were significantly up-regulated and 2 miRNAs down-regulated in glargine treated Sw1990 cells when compared with non-treated cells (2.48-fold changes on average, P < 0.01). miR-95, miR-134 and miR-34c-3p are the top three miRNAs regulated by glargine (3.65-fold, 2.67-fold and 2.60-fold changes respectively, P < 0.01) in Sw1990 cells. Stem-loop RT-PCR confirmed that high dose glargine up-regulated the expression of miR-95 and miR-134 in both Sw1990 and Panc-1 cells. The most obvious change is the apparent increase of miR-95. Forced expression of miR-95 significantly increased cell proliferation (Sw1990: 2.510 ± 0.129 vs 2.305 ± 0.187, P < 0.05; Panc-1: 2.439 ± 0.211 vs 2.264 ± 0.117, P < 0.05), invasion (Sw1990: 67.90 ± 12.33 vs 47.30 ± 5.89, P < 0.01; Panc-1: 37.80 ± 8.93 vs 30.20 ± 5.14, P < 0.01), migration (Sw1990: 101 ± 6.00 vs 51.20 ± 8.34, P < 0.01; Panc-1: 91.80 ± 9.22 vs 81.50 ± 7.47, P < 0.01) and inhibited cell apoptosis (Sw1990: 22.05% ± 1.92% vs 40.32% ± 1.93%, P < 0.05; Panc-1: 20.17% ± 0.85% vs 45.60% ± 1.43%, P < 0.05) when compared with paired negative controls, whereas knockdown of miR-95 obtained the opposite effect. Nude mice xenograft models confirmed that miR-95 promoted the growth of pancreatic cancer in vivo when compared with negative control (tumor volume: 373.82 ± 23.67 mL vs 219.69 ± 17.82 mL, P < 0.05).These observations suggested that modulation of miRNA expression may be an important mechanism underlying the biological effects of glargine." @default.
• W1995367063 created "2016-06-24" @default.
• W1995367063 creator A5007980901 @default.
• W1995367063 creator A5008456162 @default.
• W1995367063 creator A5056399898 @default.
• W1995367063 creator A5081860423 @default.
• W1995367063 date "2012-01-01" @default.
• W1995367063 modified "2023-10-12" @default.
• W1995367063 title "High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells" @default.
• W1995367063 cites W1584184269 @default.
• W1995367063 cites W1969362786 @default.
• W1995367063 cites W1976324983 @default.
• W1995367063 cites W1992638032 @default.
• W1995367063 cites W2004339436 @default.
• W1995367063 cites W2017570593 @default.
• W1995367063 cites W2030166934 @default.
• W1995367063 cites W2032768171 @default.
• W1995367063 cites W2038167014 @default.
• W1995367063 cites W2059173095 @default.
• W1995367063 cites W2068427566 @default.
• W1995367063 cites W2068435160 @default.
• W1995367063 cites W2079251691 @default.
• W1995367063 cites W2088875650 @default.
• W1995367063 cites W2093027716 @default.
• W1995367063 cites W2096330673 @default.
• W1995367063 cites W2098318517 @default.
• W1995367063 cites W2107372727 @default.
• W1995367063 cites W2108747912 @default.
• W1995367063 cites W2112417639 @default.
• W1995367063 cites W2112447641 @default.
• W1995367063 cites W2129615821 @default.
• W1995367063 cites W2133409869 @default.
• W1995367063 cites W2136512203 @default.
• W1995367063 cites W2145447528 @default.
• W1995367063 cites W2146323830 @default.
• W1995367063 cites W2148948244 @default.
• W1995367063 cites W2149431936 @default.
• W1995367063 cites W2161957137 @default.
• W1995367063 cites W2163553337 @default.
• W1995367063 cites W2164573356 @default.
• W1995367063 cites W2167078235 @default.
• W1995367063 cites W2169214947 @default.
• W1995367063 doi "https://doi.org/10.3748/wjg.v18.i21.2630" @default.
• W1995367063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3369999" @default.
• W1995367063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22690071" @default.
• W1995367063 hasPublicationYear "2012" @default.
• W1995367063 type Work @default.
• W1995367063 sameAs 1995367063 @default.
• W1995367063 citedByCount "20" @default.
• W1995367063 countsByYear W19953670632012 @default.
• W1995367063 countsByYear W19953670632013 @default.
• W1995367063 countsByYear W19953670632014 @default.
• W1995367063 countsByYear W19953670632015 @default.
• W1995367063 countsByYear W19953670632016 @default.
• W1995367063 countsByYear W19953670632018 @default.
• W1995367063 countsByYear W19953670632020 @default.
• W1995367063 countsByYear W19953670632021 @default.
• W1995367063 countsByYear W19953670632023 @default.
• W1995367063 crossrefType "journal-article" @default.
• W1995367063 hasAuthorship W1995367063A5007980901 @default.
• W1995367063 hasAuthorship W1995367063A5008456162 @default.
• W1995367063 hasAuthorship W1995367063A5056399898 @default.
• W1995367063 hasAuthorship W1995367063A5081860423 @default.
• W1995367063 hasBestOaLocation W19953670631 @default.
• W1995367063 hasConcept C104317684 @default.
• W1995367063 hasConcept C121608353 @default.
• W1995367063 hasConcept C126322002 @default.
• W1995367063 hasConcept C145059251 @default.
• W1995367063 hasConcept C153911025 @default.
• W1995367063 hasConcept C16685009 @default.
• W1995367063 hasConcept C190283241 @default.
• W1995367063 hasConcept C2778608917 @default.
• W1995367063 hasConcept C2780210213 @default.
• W1995367063 hasConcept C2780394083 @default.
• W1995367063 hasConcept C28328180 @default.
• W1995367063 hasConcept C502942594 @default.
• W1995367063 hasConcept C54009773 @default.
• W1995367063 hasConcept C54355233 @default.
• W1995367063 hasConcept C55493867 @default.
• W1995367063 hasConcept C62112901 @default.
• W1995367063 hasConcept C71924100 @default.
• W1995367063 hasConcept C81885089 @default.
• W1995367063 hasConcept C86803240 @default.
• W1995367063 hasConcept C95444343 @default.
• W1995367063 hasConceptScore W1995367063C104317684 @default.
• W1995367063 hasConceptScore W1995367063C121608353 @default.
• W1995367063 hasConceptScore W1995367063C126322002 @default.
• W1995367063 hasConceptScore W1995367063C145059251 @default.
• W1995367063 hasConceptScore W1995367063C153911025 @default.
• W1995367063 hasConceptScore W1995367063C16685009 @default.
• W1995367063 hasConceptScore W1995367063C190283241 @default.
• W1995367063 hasConceptScore W1995367063C2778608917 @default.
• W1995367063 hasConceptScore W1995367063C2780210213 @default.
• W1995367063 hasConceptScore W1995367063C2780394083 @default.
• W1995367063 hasConceptScore W1995367063C28328180 @default.
• W1995367063 hasConceptScore W1995367063C502942594 @default.
• W1995367063 hasConceptScore W1995367063C54009773 @default.
• W1995367063 hasConceptScore W1995367063C54355233 @default.

• next